Eliem Therapeutics, Inc.
ELYM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$13,670 | -$35,119 | -$45,244 | -$47,480 |
| Dep. & Amort. | -$757 | $0 | $0 | $1,845 |
| Deferred Tax | $0 | $0 | -$1,390 | -$1,845 |
| Stock-Based Comp. | $5,557 | $12,806 | $6,991 | $3,737 |
| Change in WC | $0 | $3,764 | $210 | -$4,172 |
| Other Non-Cash | -$6,692 | -$2,050 | $2,064 | $11,843 |
| Operating Cash Flow | -$15,562 | -$20,599 | -$37,369 | -$36,072 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | -$4,645 | $0 | $0 | $0 |
| Inv. Purchases | -$132,197 | -$58,449 | -$87,963 | -$114,970 |
| Inv. Sales/Matur. | $20,750 | $127,430 | $122,403 | $0 |
| Other Inv. Act. | -$5,000 | $69 | $34 | -$115 |
| Investing Cash Flow | -$121,092 | $68,981 | $34,440 | -$114,970 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $119,750 | $841 | $0 | $83,144 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $130,729 | $841 | $0 | $94,088 |
| Financing Cash Flow | $130,729 | $841 | $0 | $177,232 |
| Forex Effect | $42 | $304 | -$408 | $245 |
| Net Chg. in Cash | -$5,883 | $49,527 | -$3,337 | $26,435 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $93,112 | $43,585 | $46,922 | $20,487 |
| End Cash | $87,229 | $93,112 | $43,585 | $46,922 |
| Free Cash Flow | -$15,562 | -$20,599 | -$37,369 | -$36,072 |